• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. F
  4. Fab…
  5. Fabre Claire
🔗 Permalink
Inventor profile of:

Claire Fabre

City:

Basel

Country:

Switzerland

Published Applications:

5

Last publication date:

2025-02-06

Recent patent applications by Fabre Claire

Claire Fabre from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-06
US20250041296A1
Human necessities

NOVEL DOSING REGIMENS FOR MDM2 INHIBITORS

#2 | 2023-02-23
US20230057071A1
Chemistry; metallurgy

COMBINATION OF ANTI TIM-3 ANTIBODY MBG453 AND ANTI TGF-BETA ANTIBODY NIS793, WITH OR WITHOUT DECITABINE OR THE ANTI PD-1 ANTIBODY SPARTALIZUMAB, FOR TREATING MYELOFIBROSIS AND MYELODYSPLASTIC SYNDROME

#3 | 2023-02-23
US20230056470A1
Chemistry; metallurgy

USES OF ANTI-TGF-BETA ANTIBODIES AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#4 | 2022-09-08
US20220281970A1
Chemistry; metallurgy

Pharmaceutical Combinations

#5 | 2022-02-03
US20220031697A1
Human necessities

Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors

InventorID:

5312308 ⎘

  1. Home
  2. Inventor
  3. F
  4. Fab…
  5. Fabre Claire

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.